Price Breakdown,Chemical

The question of whether DAMGO is a peptide is a fundamental one when discussing its role in pharmacology and neuroscience. Indeed, DAMGO is definitively classified as a peptide, specifically a synthetic peptide analogue of endogenous enkephalin peptides. Its development was driven by the need for enhanced stability and high selectivity for the µ-opioid receptor (MOR).

The Chemical Blueprint of DAMGO

The precise chemical structure of DAMGO is a key determinant of its biological activity. The established chemical structure is represented by the sequence H-Tyr-D-Ala-Gly-N-MePhe-Gly-ol. This sequence reveals several important features. Firstly, it is a short chain of amino acids, a hallmark of peptides. The presence of D-Ala instead of the more common L-alanine and the N-methylation of phenylalanine (N-MePhe) are deliberate modifications that contribute to its resistance against enzymatic degradation, thereby increasing its in vivo stability compared to natural opioid peptides.

The molecular formula of DAMGO is C26H35N5O6, and its molecular weight is approximately 513.70 Da (with slight variations reported as 513.59 or 513.6 Da depending on the source and exact salt form). These chemical parameters are crucial for its identification and characterization in research settings. The CAS Number for DAMGO is 78123-71-4, serving as a unique identifier in scientific literature and databases.

DAMGO's Role as a Selective µ-Opioid Receptor Agonist

Understanding the chemical structure of DAMGO is intrinsically linked to its function. DAMGO is a highly selective µ-opioid receptor agonist. This means it preferentially binds to and activates the µ-opioid receptor (µ-OPR), exhibiting a high affinity with a reported K_d (dissociation constant) of 3.46 nM for native µ-OPR. This selectivity distinguishes it from other opioid receptors, allowing researchers to study the specific roles of the µ-opioid receptor in various biological processes.

Its designation as a DAMGO is a µ-opioid receptor (µ-OPR) selective agonist highlights its importance in research. The development of synthetic peptides like DAMGO has been instrumental in dissecting the complex pharmacology of the opioid system. While natural opioid peptides such as endomorphin-2 exist, synthetic analogues like DAMGO offer advantages in terms of stability and specificity. The synthesis of DAMGO involves modifications to the natural enkephalin peptides, including the incorporation of a D-amino acid and amidation substitutions, which reduce its susceptibility to enzymatic breakdown. This makes DAMGO a valuable tool for the study of opioid peptides and their interactions with receptors.

DAMGO in Research and Beyond

The scientific community utilizes DAMGO extensively in experimental settings to investigate the effects of µ-opioid receptor activation. Its properties as a potent µ opioid receptor agonist enable research into pain modulation, analgesia, and other neurological functions mediated by these receptors. The structures of µOR-G protein complexes bound to ligands like DAMGO are also being elucidated, providing deeper insights into the molecular mechanisms of receptor activation.

While DAMGO is a synthetic opioid drug used in scientific research, it is crucial to note that it is typically not prescribed for therapeutic use in humans. Its application is primarily within laboratories for scientific inquiry. The ability to synthesize and study peptides like DAMGO has significantly advanced our understanding of opioid receptor signaling and the development of novel therapeutic strategies. The chemical and molecular characteristics of DAMGO are central to its utility in these research endeavors.